Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development.
Blasiak A, Lim JJ, Seah SGK, Kee T, Remus A, Chye H, Wong PS, Hooi L, Truong ATL, Le N, Chan CEZ, Desai R, Ding X, Hanson BJ, Chow EK, Ho D. Blasiak A, et al. Among authors: truong atl. Bioeng Transl Med. 2020 Dec 1;6(1):e10196. doi: 10.1002/btm2.10196. eCollection 2021 Jan. Bioeng Transl Med. 2020. PMID: 33532594 Free PMC article.
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens.
Blasiak A, Truong ATL, Remus A, Hooi L, Seah SGK, Wang P, Chye H, Lim APC, Ng KT, Teo ST, Tan YJ, Allen DM, Chai LYA, Chng WJ, Lin RTP, Lye DCB, Wong JE, Tan GG, Chan CEZ, Chow EK, Ho D. Blasiak A, et al. Among authors: truong atl. NPJ Digit Med. 2022 Jun 30;5(1):83. doi: 10.1038/s41746-022-00627-4. NPJ Digit Med. 2022. PMID: 35773329 Free PMC article.
IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention.
Blasiak A, Truong ATL, Wang P, Hooi L, Chye H, Tan SB, You K, Remus A, Allen DM, Chai LYA, Chan CEZ, Lye DCB, Tan GG, Seah SGK, Chow EK, Ho D. Blasiak A, et al. Among authors: truong atl. ACS Nano. 2022 Sep 27;16(9):15141-15154. doi: 10.1021/acsnano.2c06366. Epub 2022 Aug 17. ACS Nano. 2022. PMID: 35977379
CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial).
Truong ATL, Tan SB, Wang GZ, Yip AWJ, Egermark M, Yeung W, Lee VV, Chan MY, Kumar KS, Tan LWJ, Vijayakumar S, Blasiak A, Wang LYT, Ho D. Truong ATL, et al. Eur Heart J Digit Health. 2023 Oct 24;5(1):41-49. doi: 10.1093/ehjdh/ztad063. eCollection 2024 Jan. Eur Heart J Digit Health. 2023. PMID: 38264697 Free PMC article.
Radiation therapy with phenotypic medicine: towards N-of-1 personalization.
Chong LM, Wang P, Lee VV, Vijayakumar S, Tan HQ, Wang FQ, Yeoh TDYY, Truong ATL, Tan LWJ, Tan SB, Senthil Kumar K, Hau E, Vellayappan BA, Blasiak A, Ho D. Chong LM, et al. Among authors: truong atl. Br J Cancer. 2024 Mar 21. doi: 10.1038/s41416-024-02653-3. Online ahead of print. Br J Cancer. 2024. PMID: 38514762 Review.
Intravenous thrombolysis.
Nguyen TH, Truong AT, Ngo MB, Bui CT, Dinh QV, Doan TC, Nguyen LT, Phan TC, Phan MV, Nguyen TV, Le TV. Nguyen TH, et al. Int J Stroke. 2010 Dec;5(6):516. doi: 10.1111/j.1747-4949.2010.00525.x. Int J Stroke. 2010. PMID: 21050414 No abstract available.